Global CRO capacity MAC Clinical Research operates as a leading full-service global CRO with a dedicated network of in-house and contracted sites, enabling scalable execution of Phase I-IV trials and potential partnerships for multinational studies.

Specialized facilities With MHRA-accredited Early Phase Unit, sleep laboratory, psychedelic testing suites, Phase I-IV clinics, GMP facilities, and a full laboratory, MAC offers end-to-end capabilities that can support complex and specialized trial programs your pipeline may require.

Therapeutic breadth Expertise spans CNS, Men’s and Women’s Health, and Dermatology, suggesting cross-therapeutic trial opportunities and the potential to leverage shared platforms or translational capabilities for related indications.

Sustainability edge Bronze EcoVadis rating with 66/100 placing MAC in the top quartile globally across environment, labor, ethics, and sustainable procurement signals responsible operations that can appeal to sponsors prioritizing ESG in vendor selection.

Growth indicators Recent partnerships with Initiator Pharma and Kariyapharma indicate active business development and capacity to support Phase 2a and single-centre trials, presenting opportunities to collaborate on mid-stage programs and site-based studies.